Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.00)
# 2,996
Out of 4,944 analysts
209
Total ratings
25.47%
Success rate
-1.57%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.11 | +710.81% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.74 | +982.54% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.40 | +196.88% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.19 | +82.65% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.28 | -12.28% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.67 | +1,085.54% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.53 | +650.99% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.19 | +858.63% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.78 | +742.70% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $1.23 | +4,452.85% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.08 | +825.93% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.48 | +314.77% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.00 | +200.00% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.85 | +114.69% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.54 | +65,222.88% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.60 | +515.38% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.86 | +597.67% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.28 | +7,712.50% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.69 | +2,515.14% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.29 | +773.36% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.38 | +359,489.04% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $15.97 | +3,030.87% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $14.03 | +1,610.62% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.42 | +5,533.80% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.87 | +11,394.25% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.91 | +135,263.79% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.43 | +389.51% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.50 | +1,100.00% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.54 | +1,474.80% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.35 | +115.57% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.67 | +36.43% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.93 | +29,108.92% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $36.88 | -34.92% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.46 | +234,146.58% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.39 | +1,366,708.14% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.11
Upside: +710.81%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.74
Upside: +982.54%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.40
Upside: +196.88%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.19
Upside: +82.65%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.28
Upside: -12.28%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.67
Upside: +1,085.54%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.53
Upside: +650.99%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.19
Upside: +858.63%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.78
Upside: +742.70%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $1.23
Upside: +4,452.85%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.08
Upside: +825.93%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.48
Upside: +314.77%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $10.00
Upside: +200.00%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.85
Upside: +114.69%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.54
Upside: +65,222.88%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.60
Upside: +515.38%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.86
Upside: +597.67%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.28
Upside: +7,712.50%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.69
Upside: +2,515.14%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.29
Upside: +773.36%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.38
Upside: +359,489.04%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $15.97
Upside: +3,030.87%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $14.03
Upside: +1,610.62%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.42
Upside: +5,533.80%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.87
Upside: +11,394.25%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.91
Upside: +135,263.79%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.43
Upside: +389.51%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.50
Upside: +1,100.00%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.54
Upside: +1,474.80%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $8.35
Upside: +115.57%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $3.67
Upside: +36.43%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.93
Upside: +29,108.92%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $36.88
Upside: -34.92%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.46
Upside: +234,146.58%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.39
Upside: +1,366,708.14%